Michael Bigham, Chairman and CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 4,000 shares at $14.22 ($57K) on 2018-02-05, disclosed to the SEC on 2018-02-07.
Open-market sale of $57k PRTK by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PRTK | SELL | 2022-12-14 | $164K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |